Gilead Sciences Inc.

AI Score

0
XX

Unlock

91.00
1.06 (1.18%)
At close: Jan 14, 2025, 3:59 PM
90.62
-0.42%
Pre-market Jan 15, 2025, 07:08 AM EST

Gilead Sciences Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Cell Therapy Products, Total Cell Therapy Product Sales Revenue 970.00M 960.00M 0 973.00M 937.00M 896.00M 0 796.00M 736.00M 548.00M 0 444.00M 438.00M 351.00M 16.95B 13.00M 28.00M 8.00M 10.00M 5.00M 15.00M 17.00M 28.00M 14.00M 19.00M
Cell Therapy Products, Total Cell Therapy Product Sales Revenue Growth +1.04% n/a -100.00% +3.84% +4.58% n/a -100.00% +8.15% +34.31% n/a -100.00% +1.37% +24.79% -97.93% +130261.54% -53.57% +250.00% -20.00% +100.00% -66.67% -11.76% -39.29% +100.00% -26.32% n/a
Products, Other HIV Revenue 5.07B 4.34B 201.00M 216.00M 243.00M 199.00M 254.00M 200.00M 256.00M 236.00M 250.00M 245.00M 291.00M 241.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Products, Other HIV Revenue Growth +16.84% +2060.20% -6.94% -11.11% +22.11% -21.65% +27.00% -21.88% +8.47% -5.60% +2.04% -15.81% +20.75% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Products, Total Other product sales Revenue 201.00M 224.00M 4.71B 4.68B 4.65B 4.20B 4.79B 4.50B 4.25B 3.72B 4.55B 4.20B 3.95B 3.67B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Products, Total Other product sales Revenue Growth -10.27% -95.24% +0.56% +0.73% +10.65% -12.25% +6.36% +5.96% +14.11% -18.27% +8.51% +6.25% +7.69% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Trodelvy Revenue 332.00M 309.00M 298.00M 283.00M 260.00M 222.00M 195.00M 180.00M 159.00M 146.00M 118.00M 101.00M 89.00M 72.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Trodelvy Revenue Growth +7.44% +3.69% +5.30% +8.85% +17.12% +13.85% +8.33% +13.21% +8.90% +23.73% +16.83% +13.48% +23.61% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Veklury Revenue 692.00M 555.00M 719.00M 636.00M 256.00M 573.00M 1.00B 925.00M 445.00M 1.53B 1.36B 1.92B 829.00M 1.46B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Veklury Revenue Growth +24.68% -22.81% +13.05% +148.44% -55.32% -42.70% +8.11% +107.87% -71.01% +13.12% -29.43% +131.97% -43.06% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
Europe Revenue 4.31B 4.47B 4.87B 4.13B 3.81B 4.01B 5.31B 6.37B 7.53B 5.44B 3.61B 3.33B 4.61B 4.28B
Europe Revenue Growth -3.56% -8.31% +17.87% +8.50% -4.87% -24.57% -16.56% -15.45% +38.33% +50.61% +8.42% -27.68% +7.67% n/a
Other International Revenue 3.37B 3.93B 3.16B 2.34B 1.99B 1.85B 2.60B 2.14B 3.88B 1.27B 893.10M 777.71M 652.34M 4.22B
Other International Revenue Growth -14.26% +24.15% +35.39% +17.26% +7.61% -28.82% +21.36% -44.70% +206.24% +41.75% +14.84% +19.22% -84.56% n/a
United States Revenue 19.44B 18.88B 19.27B 18.22B 16.64B 16.27B 18.19B 19.35B 21.23B 18.18B 6.70B 5.59B n/a n/a
United States Revenue Growth +2.93% -1.99% +5.76% +9.44% +2.31% -10.58% -5.99% -8.85% +16.79% +171.57% +19.73% n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 1.43B 1.37B 1.36B 1.60B 1.31B 1.85B 1.32B 2.02B 1.21B 1.36B 1.08B 1.65B 1.19B 1.35B 1.05B 1.73B 1.11B 1.24B 1.08B 1.20B 1.05B 1.09B 1.03B 1.13B 948.00M 980.00M 997.00M 1.25B 879.00M 897.00M 850.00M 992.00M 831.00M 890.00M 685.00M 1.07B 903.00M 812.00M 645.00M
Selling, General, and Administrative Revenue Growth +4.67% +0.51% -14.72% +21.44% -28.88% +40.18% -34.70% +66.53% -10.61% +25.30% -34.36% +38.66% -11.92% +28.06% -39.02% +56.42% -10.73% +15.15% -10.63% +14.45% -3.93% +6.31% -8.93% +19.30% -3.27% -1.71% -20.37% +42.43% -2.01% +5.53% -14.31% +19.37% -6.63% +29.93% -35.74% +18.05% +11.21% +25.89% n/a
Research and Development Revenue 1.40B 1.35B 1.47B 1.45B 1.46B 1.41B 1.45B 1.55B 1.15B 1.10B 3.89B 2.03B 1.15B 1.13B 1.05B 1.58B 1.16B 1.30B 1.10B 1.90B 4.99B 1.16B 1.06B 1.95B 939.00M 1.19B 937.00M 1.15B 789.00M 864.00M 931.00M 1.21B 1.14B 1.48B 1.26B 757.00M 743.00M 818.00M 696.00M
Research and Development Revenue Growth +3.49% -8.30% +1.24% -0.34% +3.55% -2.76% -6.52% +34.73% +4.26% -71.64% +91.71% +76.72% +1.15% +7.49% -33.14% +36.27% -10.85% +17.98% -42.02% -61.94% +330.17% +9.74% -45.79% +107.67% -21.22% +27.21% -18.52% +45.75% -8.68% -7.20% -22.93% +5.87% -23.11% +17.31% +67.11% +1.88% -9.17% +17.53% n/a

Create Price Alert on GILD

Your price alert will notify you when the stock price is above 91.00.

Add to Watchlist